Oligometastatic Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
5 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Oligometastatic Prostate Cancer?
BioSniper tracks 5 drugs in development for Oligometastatic Prostate Cancer across 1 company.
How many clinical trials target Oligometastatic Prostate Cancer?
There are 1 clinical trial targeting Oligometastatic Prostate Cancer tracked by BioSniper.
What is the prevalence of Oligometastatic Prostate Cancer?
The estimated prevalence of Oligometastatic Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Oligometastatic Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis